CRNX Crinetics Pharmaceuticals, Inc.
8-K Current Report
Filed: March 3, 2026
Health Care
Pharmaceutical PreparationsCrinetics Pharmaceuticals, Inc. (CRNX) 8-K current report filed with SEC EDGAR on March 3, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 4.01: Changes in Registrant's Certifying Accountant
AI Filing Analysis8-K
Item 4.01 · Changes in Registrant's Certifying Accountant
- • BDO dismissed as auditor effective Feb 27, 2026; replaced by PricewaterhouseCoopers LLP for fiscal year 2026
- • Clean transition: no disagreements, no reportable events, no adverse opinions in BDO's reports for FY2024 and FY2025
Other Crinetics Pharmaceuticals, Inc. 8-K Filings
Get deeper insights on Crinetics Pharmaceuticals, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.